Weekly cisplatin or gemcitabine concomitant with radiation in the management of locally advanced carcinoma cervix: Results from an observational study

Journal of Gynecologic Oncology

Volumn 20, Issue 4, 2009, Pages 221-226

  Verma, Arun K ^a   Arya, Ashok Kumar ^b   Kumar, Milind ^a   Kumar, Anuj ^b   Gupta, Sweety ^a   Sharma, D N ^a   Rath, G K ^a  

^a S N MEDICAL COLLEGE   (India)

^b INSTITUTE ROTARY CANCER HOSPITAL   (India)

Author keywords

Chemoradiation; Gemcitabine; Locally advanced carcinoma cervix; Weekly cisplatin

Indexed keywords

CISPLATIN; COBALT 60; DEXAMETHASONE; GEMCITABINE; MAGNESIUM SULFATE; MANNITOL; ONDANSETRON; RANITIDINE;

ADULT; ADVANCED CANCER; AGED; ANEMIA; ARTICLE; BLADDER DYSFUNCTION; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SURVIVAL; CLINICAL ARTICLE; DISEASE FREE SURVIVAL; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; HUMAN; INTESTINE OBSTRUCTION; LEUKOPENIA; NEPHROTOXICITY; OBSERVATIONAL STUDY; OVERALL SURVIVAL; RADIATION DOSE; RECTUM HEMORRHAGE; SKIN FIBROSIS; SKIN TOXICITY; THROMBOCYTOPENIA; TREATMENT DURATION; TREATMENT RESPONSE; UTERINE CERVIX CARCINOMA;

EID: 77957996657     PISSN: 20050380     EISSN: 20050399     Source Type: Journal    
DOI: 10.3802/jgo.2009.20.4.221     Document Type: Article

References (20)

1. Thomas GM. Concurrent chemotherapy and radiation for locally advanced cervical cancer: the new standard of care. Semin Radiat Oncol 2000;10:44-50.
2. Green J, Kirwan J, Tierney J, Vale C, Symonds P, Fresco L, et al. Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix. Cochrane Database Syst Rev 2005; (3): CD002225.
3. van Moorsel CJ, Veerman G, Bergman AM, Guechev A, Vermorken JB, Postmus PE, et al. Combination chemotherapy studies with gemcitabine. Semin Oncol 1997;24(2 Suppl 7): S7-17-S7-23.
4. Schilder RJ, Blessing J, Cohn DE. Evaluation of gemcitabine in previously treated patients with non-squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group. Gynecol Oncol 2005;96:103-7.
5. Burnett AF, Roman LD, Garcia AA, Muderspach LI, Brader KR, Morrow C P. A phase II study of gemcitabine and cisplatin in patients with advanced, persistent, or recurrent squamous cell carcinoma of the cervix. Gynecol Oncol 2000;76:63-6.
6. Brewer CA, Blessing JA, Nagourney RA, McMeekin DS, Lele S, Zweizig SL. Cisplatin plus gemcitabine in previously treated squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group. Gynecol Oncol 2006;100:385-8.
7. Matulonis UA, Campos S, Duska L, Krasner CN, Atkinson T, Penson RT, et al. Phase I/II dose finding study of combination cisplatin and gemcitabine in patients with recurrent cervix cancer. Gynecol Oncol 2006;103:160-4.
8. Lorvidhaya V, Chitapanarux I, Sangruchi S, Lertsanguansinchai P, Kongdanarat Y, Tangkaratt S, et al. Concurrent mitomycin C, 5-fluorouracil, and radiotherapy in the treatment of locally advanced carcinoma of cervix: a randomized trial. Int J Radiat Oncol Biol Phys 2003;55:1226-32.
9. Duenas-Gonzalez A, Lopez-Graniel C, Gonzalez A, Gomez E, Rivera L, Mohar A, et al. Induction chemotherapy with gemcitabine and oxaliplatin for locally advanced cervical carcinoma. Am J Clin Oncol 2003;26:22-5.
10. Termrungruanglert W, Tresukosol D, Vasuratna A, Sittisomwong T, Lertkhachonsuk R, Worasethsin P, et al. Neoadjuvant gemcitabine and cisplatin in (bulky) squamous cell carcinoma of the cervix stage IB2 and IIA. ASCO Annual Meeting 2002, Abstract 2542.
11. Pattaranutaporn P, Thirapakawong C, Chansilpa Y, Therasakvichya S, leumwananontachai N, Thephamongkhol K. Phase II study of concurrent gemcitabine and radiotherapy in locally advanced stage IIIB cervical carcinoma. Gynecol Oncol 2001;81:404-7.
12. Porras AR, Valencia N, Bastarrachea J. Weekly gemcitabine concurrently to external radiotherapy for cervical cancer stage IB2-IVA. ASCO Annual Meeting 2003, Abstract 1987.
13. Rodriguez-Peral JJ. Locally advanced cervical carcinoma (LACC) treated with concurrent gemcitabine (GEM) and radiotherapy (RT). ASCO Annual Meeting 2003, Abstract 1988.
14. Zarba JJ, Jaremtchuk AV, Gonzalez Jazey P, Keropian M, Castagnino R, Mina C, et al. A phase I-II study of weekly cisplatin and gemcitabine with concurrent radiotherapy in locally advanced cervix carcinoma. Ann Oncol 2003;14:1285-90.
15. Umanzor J, Aguiluz M, Pineda C, Andrade S, Erazo M. Concurrent Chemoradiation in locally advanced cervical carcinoma (LACC): role of a combination of cisplatin, gemcitabine and radiotherapy-a phase II trial. ASCO Annual Meeting 2003, Abstract 1953.
16. Bhatt ML, Matin A, Srivastava M, Pant MC, Srivastava K, Gupta S, et al. Evaluation of gemcitabine versus cisplatinum as an adjunct to radiotherapy in locally advanced carcinoma uterine cervix. ASCO Annual Meeting 2007, Abstract 16012.
17. Swisher EM, Swensen RE, Greer B, Tamimi H, Goff BA, Garcia R, et al. Weekly gemcitabine and cisplatin in combination with pelvic radiation in the primary therapy of cervical cancer: a phase I trial of the Puget Sound Oncology Consortium. Gyne Oncol Oncol 2006;101:429-35.
18. Cetina L, Rivera L, Candelaria M, de la Garza J, Duenas-Gonzalez A. Chemoradiation with gemcitabine for cervical cancer in patients with renal failure. Anticancer Drugs 2004;15:761-6.
19. Chumworathayi B, Yuenyao P, Tangvorapongchai V, Luanratanakorn S, Pattamadilok J, Krusun S. Weekly gemcitabine and cisplatin concurrent with pelvic irradiation for primary therapy of cervical cancer: report of the first seven cases in Thai women. Radiat Med 2007;25:474-9.
20. Rose PG, Degeest K, McMeekin S, Fusco N. A phase I study of gemcitabine followed by cisplatin concurrent with whole pelvic radiation therapy in locally advanced cervical cancer: a Gynecologic Oncology Group study. Gynecol Oncol 2007;107:274-9.